Acrux Limited

ASX:ACR 주식 보고서

시가총액: AU$15.4m

Acrux 과거 수익 실적

과거 기준 확인 0/6

Acrux has been growing earnings at an average annual rate of 22.4%, while the Pharmaceuticals industry saw earnings growing at 35.4% annually. Revenues have been growing at an average rate of 57.9% per year.

주요 정보

22.4%

수익 성장률

34.0%

EPS 성장률

Pharmaceuticals 산업 성장31.2%
매출 성장률57.9%
자기자본 수익률-177.0%
순이익-113.9%
최근 수익 업데이트30 Jun 2024

최근 과거 실적 업데이트

Recent updates

Here's Why Shareholders May Want To Be Cautious With Increasing Acrux Limited's (ASX:ACR) CEO Pay Packet

Nov 16
Here's Why Shareholders May Want To Be Cautious With Increasing Acrux Limited's (ASX:ACR) CEO Pay Packet

It's Unlikely That Acrux Limited's (ASX:ACR) CEO Will See A Huge Pay Rise This Year

Nov 16
It's Unlikely That Acrux Limited's (ASX:ACR) CEO Will See A Huge Pay Rise This Year

We Think Acrux (ASX:ACR) Needs To Drive Business Growth Carefully

Sep 21
We Think Acrux (ASX:ACR) Needs To Drive Business Growth Carefully

Here's Why We're Watching Acrux's (ASX:ACR) Cash Burn Situation

May 20
Here's Why We're Watching Acrux's (ASX:ACR) Cash Burn Situation

Is Acrux (ASX:ACR) In A Good Position To Invest In Growth?

Feb 04
Is Acrux (ASX:ACR) In A Good Position To Invest In Growth?

Here's What We Think About Acrux's (ASX:ACR) CEO Pay

Dec 14
Here's What We Think About Acrux's (ASX:ACR) CEO Pay

수익 및 비용 분석

Acrux 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

ASX:ACR 수익, 비용 및 수입 (AUD Millions )
날짜수익수익G+A 비용R&D 비용
30 Jun 245-660
31 Mar 248-360
31 Dec 2311-160
30 Sep 2310-160
30 Jun 238-160
31 Mar 235-460
31 Dec 222-860
30 Sep 222-960
30 Jun 222-1070
31 Mar 221-1070
31 Dec 211-1070
30 Sep 211-1170
30 Jun 211-1370
31 Mar 211-127-1
31 Dec 202-117-2
30 Sep 201-106-1
30 Jun 201-960
31 Mar 200-1061
31 Dec 19-1-1172
30 Sep 190-1071
30 Jun 191-870
31 Mar 192-970
31 Dec 183-970
30 Sep 183-1280
30 Jun 183-1480
31 Mar 188-1580
31 Dec 1712-1590
30 Sep 1718-880
30 Jun 1724070
31 Mar 1724570
31 Dec 16251060
30 Sep 16271160
30 Jun 16291350
31 Mar 16291350
31 Dec 15291450
30 Sep 15271250
30 Jun 15251150
31 Mar 15251140
31 Dec 14241040
30 Sep 14391940
30 Jun 14542840
31 Mar 14552940
31 Dec 13553040

양질의 수익: ACR is currently unprofitable.

이익 마진 증가: ACR is currently unprofitable.


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: ACR is unprofitable, but has reduced losses over the past 5 years at a rate of 22.4% per year.

성장 가속화: Unable to compare ACR's earnings growth over the past year to its 5-year average as it is currently unprofitable

수익 대 산업: ACR is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (46.5%).


자기자본 수익률

높은 ROE: ACR has a negative Return on Equity (-177.05%), as it is currently unprofitable.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기